Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 368

1.

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter.

Tabibian JH, Lindor KD.

J Hepatol. 2019 Jan 6. pii: S0168-8278(18)32623-0. doi: 10.1016/j.jhep.2018.12.006. [Epub ahead of print] No abstract available.

PMID:
30626486
2.

Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.

Cheung AC, Lammers WJ, Murillo Perez CF, van Buuren HR, Gulamhusein A, Trivedi PJ, Lazaridis KN, Ponsioen CY, Floreani A, Hirschfield GM, Corpechot C, Mayo MJ, Invernizzi P, Battezzati PM, Parés A, Nevens F, Thorburn D, Mason AL, Carbone M, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lindor KD, Lleo A, Poupon R, Janssen HL, Hansen BE; Global PBC Study Group.

Clin Gastroenterol Hepatol. 2019 Jan 4. pii: S1542-3565(19)30001-1. doi: 10.1016/j.cgh.2018.12.028. [Epub ahead of print]

PMID:
30616022
3.

Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa DM, Lindor KD.

Clin Liver Dis. 2018 Aug;22(3):589-601. doi: 10.1016/j.cld.2018.03.009. Review.

PMID:
30259855
4.

Primary sclerosing cholangitis in children versus adults: lessons for the clinic.

Adike A, Carey EJ, Lindor KD.

Expert Rev Gastroenterol Hepatol. 2018 Sep 10:1-8. doi: 10.1080/17474124.2018.1521719. [Epub ahead of print]

PMID:
30199272
5.

Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.

Tabibian JH, Ali AH, Lindor KD.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):427-432.

6.

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases.

Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M.

Hepatology. 2019 Jan;69(1):394-419. doi: 10.1002/hep.30145. Epub 2018 Nov 6. No abstract available.

PMID:
30070375
7.

Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practices.

Hilscher MB, Tabibian JH, Carey EJ, Gostout CJ, Lindor KD.

Hepatol Commun. 2018 May 4;2(7):836-844. doi: 10.1002/hep4.1194. eCollection 2018 Jul.

8.

Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.

Tabibian JH, Ali AH, Lindor KD.

Gastroenterol Hepatol (N Y). 2018 May;14(5):293-304.

9.

Managing PBC: Expanding the Provider Comfort Zone.

Chascsa DM, Lindor KD.

Dig Dis Sci. 2018 Oct;63(10):2487-2488. doi: 10.1007/s10620-018-5162-9. No abstract available.

PMID:
29948561
10.

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry.

Kuo A, Gomel R, Safer R, Lindor KD, Everson GT, Bowlus CL.

Clin Gastroenterol Hepatol. 2018 Apr 26. pii: S1542-3565(18)30409-9. doi: 10.1016/j.cgh.2018.04.047. [Epub ahead of print]

PMID:
29705262
11.

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis.

Ponsioen CY, Lindor KD, Mehta R, Dimick-Santos L.

Hepatology. 2018 Sep;68(3):1174-1188. doi: 10.1002/hep.29882. Epub 2018 Aug 31. Review.

PMID:
29574971
12.

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian JH, Lindor KD.

Aliment Pharmacol Ther. 2018 Apr;47(8):1226-1227. doi: 10.1111/apt.14568. No abstract available.

PMID:
29574873
13.

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis.

Cholankeril G, Gonzalez HC, Satapathy SK, Gonzalez SA, Hu M, Khan MA, Yoo ER, Li AA, Kim D, Nair S, Wong RJ, Kwo PY, Harrison SA, Younossi ZM, Lindor KD, Ahmed A.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):965-973.e2. doi: 10.1016/j.cgh.2017.12.017. Epub 2018 Feb 8.

PMID:
29427734
14.

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis.

Damman JL, Rodriguez EA, Ali AH, Buness CW, Cox KL, Carey EJ, Lindor KD.

Aliment Pharmacol Ther. 2018 Apr;47(7):886-895. doi: 10.1111/apt.14540. Epub 2018 Feb 7. Review.

PMID:
29411404
15.

Editorial: Itching to Know: Role of Fibrates in PBC.

Levy C, Lindor KD.

Am J Gastroenterol. 2018 Jan;113(1):56-57. doi: 10.1038/ajg.2017.432.

PMID:
29311728
16.

Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis.

Ali AH, Tabibian JH, Nasser-Ghodsi N, Lennon RJ, DeLeon T, Borad MJ, Hilscher M, Silveira MG, Carey EJ, Lindor KD.

Hepatology. 2018 Jun;67(6):2338-2351. doi: 10.1002/hep.29730. Epub 2018 Apr 19.

PMID:
29244227
17.

Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.

Harms MH, Lammers WJ, Thorburn D, Corpechot C, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Dalekos GN, Bruns T, Parés A, Mason AL, Verhelst X, Kowdley KV, Goet JC, Hirschfield GM, Hansen BE, van Buuren HR.

Am J Gastroenterol. 2018 Feb;113(2):254-264. doi: 10.1038/ajg.2017.440. Epub 2017 Dec 12.

PMID:
29231188
18.

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history.

Murillo Perez CF, Goet JC, Lammers WJ, Gulamhusein A, van Buuren HR, Ponsioen CY, Carbone M, Mason A, Corpechot C, Invernizzi P, Mayo MJ, Battezzati PM, Floreani A, Pares A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Thorburn D, Hirschfield G, LaRusso NF, Lindor KD, Zachou K, Poupon R, Trivedi PJ, Verhelst X, Janssen HLA, Hansen BE; GLOBAL PBC Study Group.

Hepatology. 2018 May;67(5):1920-1930. doi: 10.1002/hep.29717. Epub 2018 Apr 6.

PMID:
29220537
19.

Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications.

Hu RW, Carey EJ, Lindor KD, Tabibian JH.

Ann Hepatol. 2017 November-December,;16(6):835-841. doi: 10.5604/01.3001.0010.5273. Review.

20.

Heterogeneity of Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis: Age Matters.

Martin P, Lindor KD.

Dig Dis Sci. 2017 Nov;62(11):3210-3211. doi: 10.1007/s10620-017-4758-9. No abstract available.

PMID:
28965148

Supplemental Content

Loading ...
Support Center